Dimercaprol

General description Patient derived organoids (PDOs) are novel in vitro 3D cell models that preserve original tissue physiology and molecular pathology, thus representing a clinically-relevant alternative to traditional 2D cell lines and an

General description Patient derived organoids (PDOs) are novel in vitro 3D cell models that preserve original tissue physiology and molecular pathology, thus representing a clinically-relevant alternative to traditional 2D cell lines and an

General description Patient derived organoids (PDOs) are novel in vitro 3D cell models that preserve original tissue physiology and molecular pathology, thus representing a clinically-relevant alternative to traditional 2D cell lines and an

An antibiotic supplement recommended for enumeration of intestinal Enterococci from surface and waste water. Storage and Shelf Life Store at 2-8°C. Use before the expiry date on the label.

Famotidine Related Compound D (Famotidine Impurity D) is an impurity of famotidine, which is a hydrophilic, cationic, histamine H2 receptor antagonist drug that effectively inhibits gastric acid secretion in humans. This product is provided as

Homopiperazine-trityl polymer-bound.

LDN-192960 is a potent inhibitor of Haspin and DYRK2 (IC50s: 10 nM and 48 nM).

A cell-permeable, PLD1/2 inhibitor (IC 50 = 1 nM and 10 nM for PLD1 and PLD2, respectively, in a CHO cell based assay, and IC 50 = 20 nM for PLD2 in a biochemical assay), that displays no activity toward MitoPLD, and is selective for PLD1 and PLD2